FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Haloperidol Tablets
Status: Currently in Shortage
»Date first posted: 10/19/2018
»Therapeutic Categories: Psychiatry

Expand all

Mylan Pharmaceuticals Inc. (Reverified 08/08/2019)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.5 mg (NDC 0378-0351-01) and (NDC 0378-0351-10) Available Other
1 mg (NDC 0378-0257-01) and (NDC 0378-0257-10) Available Other
2 mg (NDC 0378-0214-01) and (NDC 0378-0214-10) Available Other
5 mg (NDC 0378-0327-01) and (NDC 0378-0327-10) Available Other
10 mg (NDC 0378-0334-01) Available Other
20 mg (NDC 0378-0355-01) Available Other

Sandoz (Reverified 07/30/2019)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.5 mg 100 count bottle (NDC 0781-13-9101) Unavailable Discontinuation of the manufacture of the drug
0.5 mg 100 count bottle (NDC 0781-83-9101) Not Available; Target availability in 2020 Other
0.5 mg 100 count unit dose (NDC 0781-13-9113) Unavailable Discontinuation of the manufacture of the drug
1 mg 100 count bottle (NDC 0781-13-9201) Unavailable Discontinuation of the manufacture of the drug
1 mg 100 count bottle (NDC 0781-83-9201) Not Available; Target availability in 2020 Other
1 mg 100 count unit dose (NDC 0781-13-9213) Unavailable Discontinuation of the manufacture of the drug
2 mg 100 count bottle (NDC 0781-13-9801) Limited Availability Discontinuation of the manufacture of the drug
2 mg 100 count unit dose (NDC 0781-13-9213) Unavailable Discontinuation of the manufacture of the drug
5 mg 1000 count bottle (NDC 0781-13-9610) Limited Availability Discontinuation of the manufacture of the drug
5 mg 1000 count bottle (NDC 0781-83-9610) Not Available; Target availability in 2020 Other
5 mg 100 count bottle (NDC 0781-13-9601) Limited Availability Discontinuation of the manufacture of the drug
5 mg 100 count bottle (NDC 0781-83-9601) Not Available; Target availability in 2020 Other
5 mg 100 count unit dose (NDC 0781-13-9613) Unavailable Discontinuation of the manufacture of the drug
10 mg 100 count bottle (NDC 0781-13-9701) Limited Availability Discontinuation of the manufacture of the drug
10 mg 100 count bottle (NDC 0781-83-9701) Not Available; Target availability in 2020 Other
10 mg 100 count unit dose (NDC 0781-13-9713) Unavailable Discontinuation of the manufacture of the drug
20 mg 100 count bottle (NDC 0781-83-9301) Not Available; Target availability in 2020 Other

Zydus Pharmaceuticals USA Inc. (Revised 08/02/2019)

Company Contact Information:
609-730-1900

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
HALOPERIDOL TAB 5MG 100 CT (NDC 68382-079-01) Available The product remains on allocation to existing customers. Demand increase for the drug
HALOPERIDOL TAB 5MG 1000 CT (NDC 68382-079-10) Available The product remains on allocation to existing customers. Demand increase for the drug
HALOPERIDOL TAB 10MG 100 CT (NDC 68382-080-01) Available The product remains on allocation to existing customers. Demand increase for the drug
HALOPERIDOL TAB 20MG 100 CT (NDC 68382-081-01) Available The product remains on allocation to existing customers. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English